Pricing updated 2015-09-04. Prices are subject to change without notice.
JWH 015 is a selective aminoalkylindole peripheral cannabinoid (CB2) receptor agonist with Ki values of 13.8 and 383 nM for human recombinant CB2 and CB1 receptors, respectively.1 Using Theiler’s murine encephalomyelitis virus as a model for human multiple sclerosis (MS), treatment with WIN 55,212-
|Formulation||A crystalline solid|
|λmax||219, 320 nm|
WARNING - This product is not for human or veterinary use.
|Shipping||Room temperature in continental US; may vary elsewhere|
Download Product Insert 95 Kb PDF
Download Safety Data Sheet (SDS) 27 Kb PDF
View our Base Peak Identification Tool
View our Flipbook Identification Tool
View the Cayman Structure Database for chemical structure definitions for many Cayman products
View the Cayman Spectral Library (CSL) for ChemStation-searchable GCMS spectra of many of Caymans emerging forensic drug standards
Separate multiple batch numbers with commas
1. Pertwee, R.G. Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6 635-664 (1999).
3. Enrhart, J., Obregon, D., Mori, T., et al. Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J Neuroinflammation 2 29-41 (2005).
We offer you the deep and diverse knowledge of more than 100 in-house scientists and the expertise that comes from more than three decades of designing and developing the tools to advance biomedical research.
Cayman is know as a partner to scientists worldwide, responding to your needs with services in: